Enhancing striatal acetylcholine facilitates dopamine release and striatal output in parkinsonian mice
2024-12-03
发表期刊CELL AND BIOSCIENCE (IF:6.1[JCR-2023],7.0[5-Year])
EISSN2045-3701
卷号14期号:1
发表状态已发表
DOI10.1186/s13578-024-01328-z
摘要BackgroundL-DOPA has been considered the first-line therapy for treating Parkinson's disease (PD) via restoring striatal dopamine (DA) to normalize the activity of local spiny projection neurons (SPNs) in the direct (dSPNs) pathway and the indirect (iSPNs) pathway. While the changes in striatal acetylcholine (ACh) induced by increasing DA have been extensively discussed, their validity remains controversial. Inhibition of striatal cholinergic signaling attenuates PD motor deficits. Interestingly, enhancing striatal ACh triggers local DA release, suggesting the pro-kinetic effects of ACh in movement control. Here, we investigated the in-vivo dynamics of ACh in the dorsolateral striatum (DLS) of the 6-OHDA-lesioned mouse model after L-DOPA administration, as well as its underlying mechanism, and to explore its modulatory role and mechanism in parkinsonian symptoms.ResultsUsing in vivo fiber photometry recordings with genetically encoded fluorescent DA or ACh indicator, we found L-DOPA selectively decreased DLS ACh levels in parkinsonian conditions. DA inhibited ACh release via dopamine D2 receptors and dSPNs-mediated activation of type-A gamma-aminobutyric acid receptors on cholinergic interneurons. Restoring DLS ACh levels during L-DOPA treatment induced additional DA release by activating nicotinic acetylcholine receptors, thereby promoting the activity of dSPNs and iSPNs. Enhancing DLS ACh facilitated L-DOPA-induced turning behavior but not dyskinesia in parkinsonian mice.ConclusionsOur results demonstrated that enhancing striatal ACh facilitated the effect of L-DOPA by modulating DA tone. It may challenge the classical hypothesis of a purely competitive interaction between dopaminergic and cholinergic neuromodulation in improving PD motor deficits. Modulating ACh levels within the dopaminergic system may improve striatal DA availability in PD patients.
关键词Acetylcholine Dopamine Striatum Parkinson's disease In vivo
URL查看原文
收录类别SCI
语种英语
WOS研究方向Biochemistry & Molecular Biology
WOS类目Biochemistry & Molecular Biology
WOS记录号WOS:001369350700001
出版者BMC
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/458301
专题生命科学与技术学院
生命科学与技术学院_PI研究组_胡霁组
生命科学与技术学院_硕士生
信息科学与技术学院_硕士生
免疫化学研究所_特聘教授组_陈生弟组
通讯作者Hu, Ji; Chen, Shengdi
作者单位
1.Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China
2.Shanghai Jiao Tong Univ, Ruijin Hosp, Inst Neurol, Sch Med, Shanghai, Peoples R China
3.ShanghaiTech Univ, Inst Immunochem, Lab Translat Res Neurodegenerat Dis, Shanghai, Peoples R China
4.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
第一作者单位上海科技大学
通讯作者单位生命科学与技术学院;  上海科技大学
推荐引用方式
GB/T 7714
Li, Hongxia,Chen, Ziluo,Tan, Yuyan,et al. Enhancing striatal acetylcholine facilitates dopamine release and striatal output in parkinsonian mice[J]. CELL AND BIOSCIENCE,2024,14(1).
APA Li, Hongxia.,Chen, Ziluo.,Tan, Yuyan.,Luo, Huoqing.,Lu, Chen.,...&Chen, Shengdi.(2024).Enhancing striatal acetylcholine facilitates dopamine release and striatal output in parkinsonian mice.CELL AND BIOSCIENCE,14(1).
MLA Li, Hongxia,et al."Enhancing striatal acetylcholine facilitates dopamine release and striatal output in parkinsonian mice".CELL AND BIOSCIENCE 14.1(2024).
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Li, Hongxia]的文章
[Chen, Ziluo]的文章
[Tan, Yuyan]的文章
百度学术
百度学术中相似的文章
[Li, Hongxia]的文章
[Chen, Ziluo]的文章
[Tan, Yuyan]的文章
必应学术
必应学术中相似的文章
[Li, Hongxia]的文章
[Chen, Ziluo]的文章
[Tan, Yuyan]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 10.1186@s13578-024-01328-z.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。